Citation: | QIAO Hongzhi, SUN Minjie, XIE Ying, PING Qineng, ZONG Li. Preparation and characterization of hydrocaffeoylchitosan-copper-doxorubicin ternary coordination supermolecule for renal targeting[J]. Journal of China Pharmaceutical University, 2014, 45(4): 420-426. DOI: 10.11665/j.issn.1000-5048.20140407 |
[1] |
Dolman ME,Harmsen S,Storm G,et al.Drug targeting to the kidney:advances in the active targeting of therapeutics to proximal tubular cells[J].Adv Drug Deliv Rev,2010,62(14):1 344-1 357.
|
[2] |
Suzuki K,Susaki H,Okuno S,et al.Renal drug targeting using a vector ″alkylglycoside″[J].J Pharmacol Exp Ther,1999,288(1):57-64.
|
[3] |
Zhang Z,Zheng Q,Han J,et al.The targeting of 14-succinate triptolide-lysozyme conjugate to proximal renal tubular epithelial cells[J].Biomaterials,2009,30(7):1 372-1 381.
|
[4] |
Prakash J,van Loenen-Weemaes AM,Haas M,et al.Renal-selective delivery and angiotensin-converting enzyme inhibition by subcutaneously administered captopril-lysozyme[J].Drug Metab Dispos,2005,33(5):683-688.
|
[5] |
Yuan ZX,Zhang ZR,Zhu D,et al.Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan[J].Mol Pharm,2009,6(1):305-314.
|
[6] |
Uehara T,Ishii D,Uemura T,et al.gamma-Glutamyl PAMAM dendrimer as versatile precursor for dendrimer-based targeting devices[J].Bioconjug Chem,2010,21(1):175-181.
|
[7] |
Kamada H,Tsutsumi Y,Sato-Kamada K,et al.Synthesis of a poly(vinylpyrrolidone-co-dimethyl maleic anhydride)co-polymer and its application for renal drug targeting[J].Nat Biotechnol,2003,21(4):399-404.
|
[8] |
Schechter B, Arnon R, Colas C, et al. Renal accumulation of streptavidin:potential use for targeted therapy to the kidney[J].Kidney Int,1995,47(5):1 327-1 335.
|
[9] |
Xing L,Zheng H,Cao Y,et al.Coordination polymer coated mesoporous silica nanoparticles for pH-responsive drug release[J].Adv Mater,2012,24(48):6 433-6 437.
|
[10] |
Ryu JH,Lee Y,Kong WH,et al.Catechol-functionalized chitosan/pluronic hydrogels for tissue adhesives and hemostatic materials[J].Biomacromolecules,2011,12(7):2 653-2 659.
|
[11] |
Niu J,Su Z,Xiao Y,et al.Octreotide-modified and pH-triggering polymeric micelles loaded with doxorubicin for tumor targeting delivery[J].Eur J Pharm Sci,2012,45(1/2):216-226.
|
[12] |
Deshayes S,Cabral H,Ishii T,et al.Phenylboronic acid-installed polymeric micelles for targeting sialylated epitopes in solid tumors[J].J Am Chem Soc,2013,135(41):15 501-15 507.
|
[13] |
Xing L,Zheng H,Che S.A pH-responsive cleavage route based on a metal-organic coordination bond[J].Chemistry,2011,17(26):7 271-7 275.
|
[1] | YAO Lei, QU Linlin, FAN Daidi. Effects of rare ginsenoside on idiopathic pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2023, 54(5): 607-613. DOI: 10.11665/j.issn.1000-5048.2023042002 |
[2] | QIAN Xiuhui, SUN Jing, FU San, TANG Xiaoyan, XU Xianghong, ZHANG Mian. Effect of intratracheal instillation of PM2.5 suspensionon pulmonary fibrosis in mice and the intervention of neotuberostemonine[J]. Journal of China Pharmaceutical University, 2021, 52(4): 455-462. DOI: 10.11665/j.issn.1000-5048.20210408 |
[3] | LI Xiaoshi, WU Xunxun, ZHENG Zuguo, YANG Hua, LI Ping. Advances of long noncoding RNAs in myocardial fibrosis[J]. Journal of China Pharmaceutical University, 2020, 51(6): 646-654. DOI: 10.11665/j.issn.1000-5048.20200602 |
[4] | CAI Yanfei, WAN Aini, CHEN Yun, JIN Jian. Anti-liver fibrosis activities of the extracellular domain of transforming growth factor beta type II receptor fusion protein in vivo[J]. Journal of China Pharmaceutical University, 2019, 50(2): 246-252. DOI: 10.11665/j.issn.1000-5048.20190217 |
[5] | XIE Weina, DING Qi, SUN Jing, ZHANG Chaofeng, ZHANG Mian, XU Xianghong. Protective effects of Baibu Tang on bleomycin-induced pulmonary fibrosis in mice[J]. Journal of China Pharmaceutical University, 2018, 49(4): 483-489. DOI: 10.11665/j.issn.1000-5048.20180415 |
[6] | FAN Qianqian, XING Lei, QIAO Jianbin, ZHANG Chenglu, JIANG Hulin. Advances in drug delivery systems for the treatment of liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(3): 263-271. DOI: 10.11665/j.issn.1000-5048.20180302 |
[7] | ZHAO Limeng, WANG Shuzhen. Therapeutic applications of small molecule kinase inhibitors in liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(2): 147-157. DOI: 10.11665/j.issn.1000-5048.20180203 |
[8] | XIANG Juan, YU Ping, LI Mingdan, ZHANG Chaofeng, XU Xianghong, ZHANG Mian. Protective effects of stemona alkaloids on mice with bleomycin-induced pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2017, 48(1): 76-81. DOI: 10.11665/j.issn.1000-5048.20170112 |
[9] | DAI Li, ZHANG Lu, JI Hui, KONG Xiang-wen. Therapeutic effects of ZK14,a novel nitric oxide donating biphenyldicarboxylate derivative,on hepatic fibrosis in rats[J]. Journal of China Pharmaceutical University, 2009, 40(3): 254-257. |
[10] | Danshen Inhibiting Isoproterenol Induced Cardiac Hypertrophy and Fibrosis in Mice and its Mechanisms[J]. Journal of China Pharmaceutical University, 2003, (6): 84-87. |